0001652252-17-000006.txt : 20170307
0001652252-17-000006.hdr.sgml : 20170307
20170307155238
ACCESSION NUMBER: 0001652252-17-000006
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170306
FILED AS OF DATE: 20170307
DATE AS OF CHANGE: 20170307
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIO RAD LABORATORIES INC
CENTRAL INDEX KEY: 0000012208
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 941381833
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1000 ALFRED NOBEL DRIVE
CITY: HERCULES
STATE: CA
ZIP: 94547
BUSINESS PHONE: 5107247000
MAIL ADDRESS:
STREET 1: 1000 ALFRED NOBEL DRIVE
CITY: HERCULES
STATE: CA
ZIP: 94547
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Magni Giovanni
CENTRAL INDEX KEY: 0001292816
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-07928
FILM NUMBER: 17671888
MAIL ADDRESS:
STREET 1: 1000 ALFRED NOBEL DRIVE
CITY: HERCULES
STATE: CA
ZIP: 94547
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2017-03-06
0000012208
BIO RAD LABORATORIES INC
BIO, BIOB
0001292816
Magni Giovanni
C/O BIO-RAD LABORATORIES, INC.
1000 ALFRED NOBEL DRIVE
HERCULES
CA
94547
0
1
0
0
EVP, Chief Strategy Officer
Bio-Rad A Common Stock
2017-03-06
4
S
0
998
196.1637
D
12656
D
Bio-Rad A Common Stock
2017-03-06
4
M
0
3500
75.32
A
16156
D
Bio-Rad A Common Stock
2017-03-06
4
S
0
3500
195.8652
D
12656
D
Non-Qualified Stock Option (right to buy)
75.32
2017-03-06
4
M
0
3500
0
D
2017-08-01
Bio-Rad A Common Stock
3500
0
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $196.15 to $196.25, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $195.11 to $196.40, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option vested in five equal annual installments beginning August 1, 2008.
Giovanni Magni
2017-03-07